Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 941-717-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- other: component of reaction mass
- Adequacy of study:
- key study
- Study period:
- from 1998-11-10 to 1999-11-02
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study according to OECD TG 401 and EU Method B.1
Data source
Reference
- Reference Type:
- secondary source
- Title:
- No information
- Author:
- ECHA disseminated dossier
- Year:
- 1 999
- Bibliographic source:
- Dossier EC 905-013-3
- Report date:
- 1999
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- The Department of Health of the Government of the United Kingdom, 23rd March 1998
- Limit test:
- no
Test material
- Reference substance name:
- Isomenthone
- EC Number:
- 207-727-4
- EC Name:
- Isomenthone
- Cas Number:
- 491-07-6
- IUPAC Name:
- 2-isopropyl-5-methylcyclohexanone
- Test material form:
- other: colourless liquid
- Details on test material:
- - Name of test material (as cited in study report): Isomenthon
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd, Margate, Kent
- Age at study initiation: eight to twelve weeks old
- Weight at study initiation: 214-246 g (males), 201-236 g (females)
- Fasting period before study: an overnight fast immediately before dosing and for approximately three to four hours after dosing
- Housing: in groups of up to five by sex
- Diet (e.g. ad libitum): (Rat and Mouse Expanded Diet No. 1, Special Diets Services Limited, Witham, Essex, UK, ad libitum
- Water (e.g. ad libitum): mains drinking water, ad libitum
- Acclimation period: minimum of 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25
- Humidity (%): 30-70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 1999-09-09 To: 1999-10-12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 2.24 mL/kg
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: based on the results of the range-finding study - Doses:
- 1000, 1414 and 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were observed for deaths or overt signs of toxicity 1/2, 1, 2 and 4 hours after dosing and subsequently once daily for fourteen days. Individual bodyweights were recorded prior to dosing on Day 0 and on Days 7 and 14 or at death.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross lesions and other toxicological effects - Statistics:
- LD50 and 95% confidence limits were calculated by the method of Thompson. (Thompson, W.R., Bact. Reviews, 11, 115-145 (1947
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2 119 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 1 322 - <= 3 396
- Mortality:
- 2 out of 5 female rats and 1 out of 5 male rats of highest dose died one and two days after dosing. One female animal treated with 2000 mg/kg was killed in extremis one day after dosing.
- Clinical signs:
- Clinical signs of toxicity commonly noted in all dose groups were hunched posture and lethargy. Ataxia was noted in animals treated with 1414 or 2000 mg/kg. Decreased respiratory rate and laboured respiration were noted in animals treated with 1000 or 2000 mg/kg. Ptosis was commonly noted in animals treated with 2000 mg/kg with incidents of loss of righting reflex. An isolated incident of redlbrown staining around the eyes was noted in one animal treated with 1414 mg/kg. Incidents of toxicity noted in female animals treated with 2000 mg/kg were increased lacrimation, pilo-erection and splayed or tiptoe gait. One female animal treated with 2000 mg/kg was comatose prior to killing in extremis. Surviving animals recovered one to four days after dosing.
- Body weight:
- Surviving animals showed expected gain in bodyweight during the study.
- Gross pathology:
- Abnormalities noted at necropsy of the animal that was killed in extremis or animals that died during the study were haemorrhagic or abnormally red lungs, pale liver or patchy pallor of the liver, dark kidneys, slightly haemorrhagic or pale gastric mucosa, sloughing of the non-glandular epithelium of the stomach and haemorrhage of the small and large intestines. No abnormalities were noted at necropsy of animals that were killed at the end of the study.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral LD50 of the test material, Isomenthone, in the Sprague-Dawley CD strain female rat was 2119 mg/kg body weight. Male animals were considered not to be markedly more sensitive to the test material than female animals.
- Executive summary:
The acute oral toxicity of the test substance Isomenthone was studied in a GLP test according to OECD TG 401 and EU Method B.1. Groups of five animals were exposed to single oral (gavage) doses of 1000, 1414 and 2000 mg/kg bw in females and of 2000 mg/kg bw in males. Animals were observed during a period of 14 days. No mortality was observed in the low ad the mid-dose groups, whereas 2 females and 1 male of the high-dose group died within one and two days after dosing. One female animal
treated with 2000 mg/kg bw was killed in extremis one day after dosing. The LD50 and 95 % confidence limits were calculated by the method of Thompson. (Thompson, W.R., Bact. Reviews, 11, 115-145 (1947).)
The LD50 value for females was 2119 mg/kg bw with a 95 % confidence interval of 1322 to 3396 mg/kg bw. Male animals were considered not to be markedly more sensitive to the test material than female animals. Clinical signs of toxicity were ataxia, hunched posture, lethargy, increased lacrimation, pilo-erection, ptosis, decreased respiratory rate, laboured respiration, redlbrown staining around the eyes, loss of righting reflex and splayed or tiptoe gait. Surviving animals recovered one to four days after dosing.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
